CELESTICA INC (CLS) Stock Analyst Earnings Estimates
NYSE:CLS - New York Stock Exchange, Inc. - CA15101Q2071 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.635B -1.97% | 7.25B 28.67% | 7.961B 9.81% | 9.71B 21.97% | 10.582B 8.98% | 11.855B 12.03% | 13.947B 17.65% | |
| EBITDA YoY % growth | 299.3M 22.31% | 414.8M 38.59% | 558.8M 34.72% | 779.15M 39.43% | 874.07M 12.18% | 961.22M 9.97% | 1.184B 23.18% | |
| EBIT YoY % growth | 173M 44.17% | 270M 56.07% | 398.4M 47.56% | 627.07M 57.40% | 705.34M 12.48% | 783.76M 11.12% | 1.033B 31.80% | |
| Operating Margin | 3.07% | 3.72% | 5.00% | 6.46% | 6.67% | 6.61% | 7.41% | |
| EPS YoY % growth | 1.31 32.32% | 1.91 45.80% | 2.43 27.23% | 3.90 60.56% | 4.48 14.87% | 5.03 12.34% | 6.48 28.79% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.06 39.76% | 1.01 17.64% | 1.08 18.94% | 1.20 14.92% | 1.23 16.01% | 1.18 16.80% | 1.20 11.04% | 1.31 9.86% | 1.45 18.03% |
| Revenue Q2Q % growth | 2.537B 18.52% | 2.411B 9.15% | 2.557B 6.90% | 2.756B 10.26% | 2.811B 10.80% | 2.773B 15.01% | 2.778B 8.64% | 3.03B 9.94% | 3.161B 12.45% |
| EBITDA Q2Q % growth | 209.15M -25.44% | 200.36M 23.83% | 210.86M -6.66% | 228.71M -17.97% | 231.73M 10.80% | 230.28M 14.93% | 233.31M 10.65% | 255.53M 11.73% | 277.75M 19.86% |
| EBIT Q2Q % growth | 169.83M 41.41% | 160.82M 36.06% | 171.27M 24.74% | 187.83M 31.90% | 191.19M 12.58% | 186.85M 16.19% | 189.88M 10.87% | 207.05M 10.23% | 227.25M 18.86% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.04 60.00% | 0.94 | 0.10 | 10.52% |
| Q2 2024 Q2Q % growth | 0.91 65.45% | 0.82 | 0.09 | 10.78% |
| Q1 2024 Q2Q % growth | 0.86 82.98% | 0.73 | 0.13 | 17.99% |
| Q4 2023 Q2Q % growth | 0.76 35.71% | 0.68 | 0.08 | 11.20% |
| Q3 2023 Q2Q % growth | 0.65 25.00% | 0.60 | 0.05 | 7.56% |
| Q2 2023 Q2Q % growth | 0.55 25.00% | 0.48 | 0.07 | 14.64% |
| Q1 2023 Q2Q % growth | 0.47 20.51% | 0.46 | 0.01 | 2.27% |
| Q4 2022 Q2Q % growth | 0.56 27.27% | 0.55 | 0.01 | 2.05% |
| Q3 2022 Q2Q % growth | 0.52 48.57% | 0.45 | 0.07 | 14.84% |
| Q2 2022 Q2Q % growth | 0.44 46.67% | 0.43 | 0.01 | 3.02% |
| Q1 2022 Q2Q % growth | 0.39 77.27% | 0.36 | 0.03 | 9.80% |
| Q4 2021 Q2Q % growth | 0.44 69.23% | 0.38 | 0.06 | 15.02% |
| Q3 2021 Q2Q % growth | 0.35 9.37% | 0.33 | 0.02 | 6.63% |
| Q2 2021 Q2Q % growth | 0.30 20.00% | 0.25 | 0.05 | 21.24% |
| Q1 2021 Q2Q % growth | 0.22 37.50% | 0.20 | 0.02 | 7.57% |
| Q4 2020 Q2Q % growth | 0.26 44.44% | 0.25 | 0.01 | 3.49% |
| Q3 2020 Q2Q % growth | 0.32 146.15% | 0.25 | 0.07 | 27.37% |
| Q2 2020 Q2Q % growth | 0.25 108.33% | 0.15 | 0.10 | 71.37% |
| Q1 2020 Q2Q % growth | 0.16 33.33% | 0.10 | 0.06 | 58.42% |
| Q4 2019 Q2Q % growth | 0.18 | 0.15 | 0.03 | 17.94% |
| Q3 2019 Q2Q % growth | 0.13 | 0.12 | 0.01 | 5.50% |
| Q2 2019 Q2Q % growth | 0.12 | 0.12 | 0.00 | -0.99% |
| Q1 2019 Q2Q % growth | 0.12 | 0.16 | -0.04 | -26.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 2.5B 22.33% | 2.441B | 58.5M | 2.40% |
| Q2 2024 Q2Q % growth | 2.392B 23.33% | 2.27B | 121.9M | 5.37% |
| Q1 2024 Q2Q % growth | 2.209B 20.19% | 2.12B | 88.9M | 4.19% |
| Q4 2023 Q2Q % growth | 2.141B 4.79% | 2.103B | 37.5M | 1.78% |
| Q3 2023 Q2Q % growth | 2.043B 6.24% | 2.011B | 32.3M | 1.61% |
| Q2 2023 Q2Q % growth | 1.939B 12.94% | 1.841B | 98.4M | 5.34% |
| Q1 2023 Q2Q % growth | 1.838B 17.29% | 1.835B | 2.8M | 0.15% |
| Q4 2022 Q2Q % growth | 2.043B 35.08% | 1.988B | 54.6M | 2.75% |
| Q3 2022 Q2Q % growth | 1.923B 31.07% | 1.751B | 172.3M | 9.84% |
| Q2 2022 Q2Q % growth | 1.717B 20.90% | 1.683B | 34.2M | 2.03% |
| Q1 2022 Q2Q % growth | 1.567B 26.88% | 1.492B | 74.9M | 5.02% |
| Q4 2021 Q2Q % growth | 1.512B 9.05% | 1.522B | -9.9M | -0.65% |
| Q3 2021 Q2Q % growth | 1.467B -5.36% | 1.501B | -33.6M | -2.24% |
| Q2 2021 Q2Q % growth | 1.42B -4.83% | 1.391B | 29.3M | 2.11% |
| Q1 2021 Q2Q % growth | 1.235B -6.35% | 1.229B | 5.9M | 0.48% |
| Q4 2020 Q2Q % growth | 1.387B -7.05% | 1.42B | -33.4M | -2.35% |
| Q3 2020 Q2Q % growth | 1.551B 2.15% | 1.505B | 45.5M | 3.02% |
| Q2 2020 Q2Q % growth | 1.492B 3.24% | 1.324B | 168.4M | 12.72% |
| Q1 2020 Q2Q % growth | 1.319B -7.99% | 1.249B | 69.6M | 5.57% |
| Q4 2019 Q2Q % growth | 1.492B | 1.486B | 5.7M | 0.38% |
| Q3 2019 Q2Q % growth | 1.518B | 1.459B | 58.9M | 4.04% |
| Q2 2019 Q2Q % growth | 1.446B | 1.457B | -11.4M | -0.78% |
| Q1 2019 Q2Q % growth | 1.433B | 1.516B | -82.9M | -5.47% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 24.95% | 0% | 6.08% |
| Revenue | 0% | 5.8% | 0% | 1.66% |